-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

617.O1.3 617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: MRD and Novel molecular Markers

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
AML, Adult, Diseases, Non-Biological, Combinations, Therapies, chemotherapy, Biological Processes, Technology and Procedures, cytogenetics, Study Population, Myeloid Malignancies, Clinically relevant, genetic profiling, genomics, flow cytometry, NGS, RNA sequencing, serologic tests, WGS
Saturday, December 5, 2020: 2:00 PM-3:30 PM
Moderators:
Thomas Mercher, and Anna Hagstroem-Andersson, PhD, Lund University
Disclosures:
No relevant conflicts of interest to declare.
2:00 PM

Natasha S Anstee, PhD1,2*, Giovanna Pomilio1,2*, Mark Levis, MD, PhD3,4, Sarah MacRaild1*, Michael Murray, PhD, DSc4,5*, Tristan Rawling, PhD6*, Glen A Kennedy, MBBS FRACP FRCPA4,7*, Andrew Grigg, MBBS, MD, FRACP, FRCPA4,8*, Anthony Schwarer, MBBS, MD, FRACP, FRCPA4,9*, Anoop Kumar Enjeti, MBBS, FRCPA, FRACP, PhD, MD, MRCP4,10, James D'Rozario, MBBS, FRACP, FRCPA4,11, Paula Marlton, MBBS FRACP FRCPA4,12, Ian Bilmon, BMBS, FRACP, FRCPA4,13*, Adam Ivey, BSc, MSc, PhD1,4*, Doen Ming Ong, MBBS1,14*, Andrew W Roberts, MBBS4,15,16,17,18 and Andrew H Wei, MBBS, PhD1,2,4

1The Alfred Hospital, Melbourne, Australia
2Australian Centre for Blood Diseases, Monash University, Melbourne, Australia
3Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
4Australasian Leukaemia and Lymphoma Group (ALLG), Melbourne, Australia
5University of Sydney, Sydney, Australia
6University of Technology, Sydney, Australia
7Department of Haematology, Royal Brisbane and Women's Hospital, Brisbane, Australia
8Austin Health and Olivia Newton John Cancer Research Institute, Melbourne, Australia
9Box Hill Hospital, Melbourne, Australia
10Calvary Mater Newcastle Hospital, Sydney, Australia
11The Canberra Hospital, Canberra, Australia
12Princess Alexandra Hospital, Brisbane, Australia
13Department of Haematology and Bone Marrow Transplantation, Westmead Hospital, Sydney, NSW, Australia
14Monash University, Melbourne, Australia
15The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
16Peter MacCallum Cancer Centre, Melbourne, Australia
17University of Melbourne, Melbourne, Australia
18Royal Melbourne Hospital, Melbourne, Australia

2:15 PM

Maximilian Stahl, MD1,2, Andriy Derkach, PhD3*, Christopher Famulare, MS4*, Christina Cho, MD5,6, Sean Devlin, PhD7*, Noushin Farnoud, PhD4,8*, Kamal Menghrajani, MD1, Minal A Patel, MPH4*, Sheng F Cai, MD, PhD1,9, Mark B. Geyer, MD1,10, Andrew Dunbar, MD1, Zachary D. Epstein-Peterson, MD11, Erin McGovern, BA4*, Jessica Schulman, BSc12*, Jacob L Glass, MD, PhD1, Justin Taylor, MD13, Aaron D Viny, MD, MS1,14, Eytan M. Stein, MD1, Bartlomiej Getta, FRCPA, FRACP, MBBS1*, Maria E. Arcila, MD15,16*, Ross L. Levine, MD1,4, Juliet Barker, MBBS6, Brian C. Shaffer, MD6, Esperanza B. Papadopoulos, MD5,6, Boglarka Gyurkocza, MD6, Miguel-Angel Perales, MD2,6, Omar Abdel-Wahab, MD 1,14, Elli Papaemmanuil, PhD17,18, Sergio A. Giralt, MD2,19, Yanming Zhang, MD20, Mikhail Roshal, MD, PhD16, Martin S. Tallman, MD 2,21 and Aaron D Goldberg, MD, PhD22

1Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Weill Cornell Medical College, New York, NY
3Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
4Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Medicine, Weill Cornell Medical College, New York, NY
6Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
7Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
8Center for Molecular Oncology and Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
9Center for Epigenetic Research, Memorial Sloan Kettering Cancer Center, New York, NY
10Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY
11Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
12Center for Hematologic malignancies, Memorial Sloan Kettering Cancer Center, New York, NY
13Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, Miami, FL
14Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY
15Molecular Diagnostics Service, Memorial Sloan Kettering Cancer Center, New York, NY
16Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
17Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
185Computational Oncology Service, Department of Epidemiology & Biostatistics, Center for Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
19Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
20Department of Pathology, Memorial Sloan Kettering Cancer Center, Chicago, IL
21Memorial Sloan-Kettering Cancer Center, New York, NY
22Department of Medicine, Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY

2:30 PM

Rhonda E. Ries, MA1*, Timothy Junius Triche Jr., PhD2,3,4, Jenny L. Smith, MSc, MEd1*, Amanda R. Leonti, MS5*, Todd A. Alonzo, PhD6,7*, Jason E Farrar, MD8, Xiaolong Chen, PhD9*, Yanling Liu, PhD9*, Timothy Shaw, PhD10*, Benjamin J. Huang, MD11*, Yi-Cheng Wang, MS6*, Robert B. Gerbing, MA6*, Betsy A Hirsch, PhD12*, Susana C. Raimondi, PhD13, Alan S. Gamis, MD, MPH14, Richard Aplenc, MD, PhD15, Jinghui Zhang, PhD9*, E. Anders Kolb, MD16, Xiaotu Ma, PhD9* and Soheil Meshinchi, MD, PhD17

1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
2Van Andel Research Institute, Grand Rapids, MI
3Michigan State University, East Lansing, MI
4Keck School of Medicine of University of Southern California, Los Angeles, CA
5Clinical Research Division, Fred Hutchinson Cancer Research Center, Mountlake Terrace, WA
6Children's Oncology Group, Monrovia, CA
7University of Southern California, Los Angeles, CA
8University of Arkansas For Medical Sciences, Little Rock, AR
9Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN
10Computational Biology, St. Jude Children's Hospital, Memphis, TN
11Department of Pediatrics, University of California, San Francisco, San Francisco, CA
12Division of Molecular Pathology and Genomics, University of Minnesota, Minneapolis, MN
13Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
14Hematology/Oncology, Children's Mercy Hospitals and Clinics, Kansas City, MO
15Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
16Center for Cancer and Blood Disorders, Nemours Alfred I. duPont Hospital for Children, Wilmington, DE
17Clinical Research Division, Fred Hutchinson Cancer Rsrch. Ctr., Seattle, WA

2:45 PM

Julia K. Herzig, PhD1*, Frank G. Rücker, MD1*, Laura K. Schmalbrock, MD1*, Tamara J. Blätte, PhD1,2*, Daniela Weber, MSc1*, Sabrina Skambraks1*, Silke Kapp-Schwoerer, MD1*, Andrea Corbacioglu, PhD1*, Verena I Gaidzik, MD1, Peter Paschka, MD1, Ekaterina Panina, MD1*, Nikolaus Jahn, MD1*, Anika Schrade, PhD1*, Frauke Theis, MD1*, Sibylle Cocciardi, PhD1*, Walter Fiedler, MD3, Helmut R. Salih4, Gerald Wulf, MD5*, Hans Salwender, MD6*, Thomas Schroeder7*, Katharina S. Götze8, Thomas Kindler, MD9*, Michael Luebbert10, Richard F. Schlenk11,12, Felicitas Thol13, Michael Heuser13, Arnold Ganser13, Hartmut Döhner1, Lars Bullinger, MD2 and Konstanze Dohner, MD1

1Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
2Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine Berlin, Berlin, Germany
3Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
4Department of Hematology and Oncology, Eberhard Karls University Tübingen, Tübingen, Germany
5Department of Hematology and Oncology, University Hospital of Göttingen, Göttingen, Germany
6Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, Hamburg, Germany
7Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Düsseldorf, Germany
8Department of Medicine III, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
9Department of Hematology, Oncology and Pneumology, University Medical Center, Johannes Gutenberg-University of Mainz, Mainz, Germany
10Department of Hematology, Oncology, and Stem-Cell Transplantation, Faculty of Medicine and Medical Center - University of Freiburg, Freiburg, Germany
11Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
12National Center of Tumor Diseases, NCT-Trial Center, German Cancer Research Center, Heidelberg, Germany
13Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

3:00 PM

Abhishek Maiti, MBBS1, Courtney D. DiNardo, MD, MSc2, Sa A Wang, MD3*, Jeffrey L. Jorgensen, MD, PhD3*, Tapan M. Kadia, MD4, Naval Daver, MD5, Nicholas J. Short, MD1, Musa Yilmaz, MD6, Naveen Pemmaraju, MD1, Gautam Borthakur, MD1, Prithviraj Bose, MD6, Ghayas C. Issa, MD1, Alessandra Ferrajoli, MD7, Elias Jabbour, MD1, Nitin Jain, MD8, Guillermo Garcia-Manero, MD1, Maro Ohanian, DO1*, Koichi Takahashi, MD, PhD9, Guillermo Montalban-Bravo, MD1*, Lucia Masarova, MD1*, Jan A. Burger, MD, PhD1, Philip A. Thompson, MB, MS10, Srdan Verstovsek, MD, PhD1, Koji Sasaki, MD6, Michael Andreeff, MD, PhD11, Caitlin R. Rausch, PharmD12*, Kathryn Montalbano13*, Sherry A. Pierce, BSN, BA1*, Hagop M. Kantarjian, MD14, Marina Konopleva, MD, PhD15 and Farhad Ravandi, MBBS16

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
3University of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, TX
4Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
5Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, TX
6Department of Leukemia, MD Anderson Cancer Center, Houston, TX
7Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
8Associate Professor of Medicine Department of Leukemia The University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
10The University of Texas MD Anderson Cancer Center, Houston, TX
11Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
12Pharmacy, MD Anderson Cancer Center, Houston, TX
13University of Texas M.D. Anderson Cancer Center, Houston, TX
14University of Texas MD Anderson Cancer Center, Houston, TX
15Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX
16Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX

3:15 PM

Ing Soo Tiong, MBBS, FRACP, FRCPA1,2,3, Richard Dillon, MA, PhD, MRCP, FRCPath4,5, Adam Ivey, BSc, MSc, PhD3*, Chung Hoow Kok, BSc, PhD6*, James Anton Kuzich, MBBS1, Nisha Thiagarajah, MBBS2,7*, Ashish Bajel, FRACP2, Nicola Potter, PhD8*, Matthew Smith, MBBS9*, Claire Hemmaway10*, Abin Thomas11*, Amanda Gilkes12*, Nigel H. Russell, MD13 and Andrew H. Wei14

1Austin Health and Olivia Newton John Cancer Research Institute, Melbourne, Australia
2Peter MacCallum Cancer Centre, Melbourne, Australia
3The Alfred Hospital and Monash University, Melbourne, Australia
4Guys and St. Thomas Hospital, London, United Kingdom
5Department of Medical and Molecular Genetics, King's College, London, United Kingdom
6Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, Australia
7The Royal Melbourne Hospital, Melbourne, Australia
8Cancer Genetics Laboratory, King's College, London, United Kingdom
9St Bartholomew's Hospital, London, United Kingdom
10Auckland City Hospital, Auckland, New Zealand
11Centre for Trials Research, Cardiff University, Cardiff, United Kingdom
12Cardiff University, Cardiff, United Kingdom
13Guy's Hospital, London, United Kingdom
14Monash University, Melbourne, Australia

*signifies non-member of ASH